Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes

• Vassiliki Kotoula ,

  * E-mail: vkotoula@auth.gr

  Affiliations Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece, Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece

  ⨯
• Sotiris Lakis,

  Affiliation Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece

  ⨯
• Ioannis S. Vlachos,

  Affiliations Molecular Diagnostics Laboratory, INRASTES, NCSR 'Demokritos', Athens, Greece, DIANA-Lab, Department of Computer and Communication Engineering, University of Thessaly, Volos, Greece

  ⨯
• Eleni Giannoulatou,

  Affiliations Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia, The University of New South Wales, New South Wales, Australia

  ⨯
• Flora Zagouri,

  Affiliation Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

  ⨯
• Zoi Alexopoulou,

  Affiliation Department of Biostatistics, Health Data Specialists Ltd, Athens, Greece

  ⨯
• Helen Gogas,

  Affiliation First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

  ⨯
• Dimitrios Pectasides,

  Affiliation Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece

  ⨯
• Gerasimos Aravantinos,

  Affiliation Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece

  ⨯
• Ioannis Efstratiou,

  Affiliation Department of Pathology, Papageorgiou Hospital, Thessaloniki, Greece

  ⨯
• George Pentheroudakis,

  Affiliation Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece

  ⨯
• Kyriaki Papadopoulou,

  Affiliation Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece

  ⨯
• Kyriakos Chatzopoulos,

  Affiliation Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece

  ⨯
• Pavlos Papakostas,

  Affiliation Oncology Unit, Hippokration Hospital, Athens, Greece

  ⨯
• Maria Sotiropoulou,

  Affiliation Department of Pathology, Alexandra Hospital, Athens, Greece

  ⨯
• Irene Nicolaou,

  Affiliation Department of Histopathology, Agii Anagriri Cancer Hospital, Athens, Greece

  ⨯
• Evangelia Razis,

  Affiliation Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece

  ⨯
• Amanda Psyrri,

  Affiliation Division of Oncology, Second Department of Internal Medicine, Attikon University Hospital, Athens, Greece

  ⨯
• Paris Kosmidis,

  Affiliation Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece

  ⨯
• Christos Papadimitriou,

  Affiliation Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

  ⨯
•  [ ... ],
• George Fountzilas

  Affiliations Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece, Aristotle University of Thessaloniki, Thessaloniki, Greece

  ⨯
• [ view all ]
• [ view less ]